NIH-funded research Sbir 2 grant

New tools to map and measure epigenetic changes in aging and Alzheimer's disease

Official title: Development of novel epigenetic biomarkers and detection reagents for aging

Funded at Epicypher, INC. · NIH-11419580 · Data updated 2026-11-12

A small grant is funding new methods to find and measure combinations of chemical tags on histones that change with aging and Alzheimer’s disease, helping identify targets and biomarkers.

More Aging research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionEpicypher, INC.
NIH-funded
Lab location1 site (Research Triangle Park, UNITED STATES)
Project startSeptember 20, 2025
Project endMay 31, 2027
Funding year2026
Award (this year)$1,249,682
NIH project number5R44AG091990-02
Project IDNIH-11419580 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include individuals at risk for or diagnosed with AD/ADRD where chromatin-based biomarkers could be informative in the future.

Less likely to help

People without aging-related concerns or AD/ADRD may not directly benefit from these basic tool development efforts.

What this research studies

This project focuses on understanding how histone modifications interact to influence aging and Alzheimer’s disease. It aims to create novel reagents and detection approaches that can reveal patterns of multiple histone marks at once, rather than one mark at a time. By uncovering pathogenic combinations, researchers hope to identify new biomarkers and potential therapeutic targets that could later benefit patients with AD/ADRD.

Why it matters

Potential benefit: If successful, patients could benefit from earlier biomarkers and new avenues for therapies targeting chromatin regulation.

How similar studies have gone: Preliminary work suggests that studying multiple histone marks together can uncover patterns not seen with single marks, making this approach promising but still exploratory.

Where this research is happening

  • Epicypher, INC.
    Research Triangle Park, United States
    Active

Researchers

  • Principal investigator: Hunt, Sabrina Robin — Epicypher, INC.
  • Study coordinator: Hunt, Sabrina Robin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.